Capricor Other Liab from 2010 to 2024

CAPR Stock  USD 19.01  0.03  0.16%   
Capricor Therapeutics Other Liabilities yearly trend continues to be relatively stable with very little volatility. Other Liabilities is likely to grow to about 15.5 M this year. During the period from 2010 to 2024, Capricor Therapeutics Other Liabilities destribution of quarterly values had range of 15.5 M from its regression line and mean deviation of  3,882,451. View All Fundamentals
 
Other Liabilities  
First Reported
2013-12-31
Previous Quarter
12.8 M
Current Value
6.6 M
Quarterly Volatility
4.5 M
 
Yuan Drop
 
Covid
Check Capricor Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Capricor Therapeutics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.1 M, Interest Expense of 2 M or Other Operating Expenses of 51.7 M, as well as many indicators such as Price To Sales Ratio of 4.94, Dividend Yield of 0.0 or PTB Ratio of 6.08. Capricor financial statements analysis is a perfect complement when working with Capricor Therapeutics Valuation or Volatility modules.
  
Check out the analysis of Capricor Therapeutics Correlation against competitors.
To learn how to invest in Capricor Stock, please use our How to Invest in Capricor Therapeutics guide.

Latest Capricor Therapeutics' Other Liab Growth Pattern

Below is the plot of the Other Liab of Capricor Therapeutics over the last few years. It is Capricor Therapeutics' Other Liabilities historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Capricor Therapeutics' overall financial position and show how it may be relating to other accounts over time.
Other Liab10 Years Trend
Slightly volatile
   Other Liab   
       Timeline  

Capricor Other Liab Regression Statistics

Arithmetic Mean4,668,664
Geometric Mean1,481,031
Coefficient Of Variation113.19
Mean Deviation3,882,451
Median3,376,259
Standard Deviation5,284,401
Sample Variance27.9T
Range15.5M
R-Value0.83
Mean Square Error9.5T
R-Squared0.69
Significance0.0001
Slope977,989
Total Sum of Squares390.9T

Capricor Other Liab History

202415.5 M
202314.8 M
202212.8 M
20173.4 M
20163.9 M
20151.4 M
20144.4 M

About Capricor Therapeutics Financial Statements

Capricor Therapeutics shareholders use historical fundamental indicators, such as Other Liab, to determine how well the company is positioned to perform in the future. Although Capricor Therapeutics investors may analyze each financial statement separately, they are all interrelated. The changes in Capricor Therapeutics' assets and liabilities, for example, are also reflected in the revenues and expenses on on Capricor Therapeutics' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Other Liabilities14.8 M15.5 M

Pair Trading with Capricor Therapeutics

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Capricor Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Capricor Therapeutics will appreciate offsetting losses from the drop in the long position's value.

Moving together with Capricor Stock

  0.73ESPR Esperion Therapeutics Buyout TrendPairCorr
  0.91EWTX Edgewise TherapeuticsPairCorr
  0.77BHC Bausch Health CompaniesPairCorr

Moving against Capricor Stock

  0.79MRK Merck Company Fiscal Year End 6th of February 2025 PairCorr
  0.72TAK Takeda PharmaceuticalPairCorr
  0.7ELAN Elanco Animal HealthPairCorr
  0.63HLN Haleon plcPairCorr
  0.62LTRN Lantern PharmaPairCorr
The ability to find closely correlated positions to Capricor Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Capricor Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Capricor Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Capricor Therapeutics to buy it.
The correlation of Capricor Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Capricor Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Capricor Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Capricor Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Additional Tools for Capricor Stock Analysis

When running Capricor Therapeutics' price analysis, check to measure Capricor Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Capricor Therapeutics is operating at the current time. Most of Capricor Therapeutics' value examination focuses on studying past and present price action to predict the probability of Capricor Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Capricor Therapeutics' price. Additionally, you may evaluate how the addition of Capricor Therapeutics to your portfolios can decrease your overall portfolio volatility.